ImmunoGen Inc
Change company Symbol lookup
Select an option...
IMGN ImmunoGen Inc
GDX VanEck Vectors Gold Miners ETF
CTVA Corteva Inc
WDC Western Digital Corp
VER VEREIT Inc
STOR STORE Capital Corp
BKCC BlackRock Capital Investment Corp
MANH Manhattan Associates Inc
RF Regions Financial Corp
QRVO Qorvo Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

ImmunoGen, Inc. is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. An ADC with the Company's technology comprises an antibody that binds to a target found on tumor cells conjugated to one of its anti-cancer agents as a payload to kill the tumor cell once the ADC has bound to its target. Its product candidates include Mirvetuximab soravtansine; IMGN779; IMGN632; and Coltuximab ravtansine. Its portfolio is led by Mirvetuximab soravtansine, a first-in-class ADC targeting folate-receptor alpha (Fra), which is in a Phase III registrational trial called FORWARD I. Its FORWARD II trial consists of cohorts assessing Mirvetuximab soravtansine in combination with Avastin (bevacizumab), Keytruda (pembrolizumab) and carboplatin. The Company has developed tubulin-acting maytansinoid payload agents, which include DM1 and DM4, as well as deoxyribonucleic acid (DNA)-alkylating agents called IGNs.

Closing Price
$4.68
Day's Change
-0.12 (-2.50%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.91
Day's Low
4.54
Volume
(Average)
Volume:
2,449,985

10-day average volume:
2,468,223
2,449,985
  • Prev Close
    4.80
  • Today's Open
    4.82
  • Day's Range
    4.54-4.91
  • Avg Vol (10-day)
    2.5M
  • Last (time)
    3:59p ET 05/29/20
  • Last (size)
    30
  • 52-Wk Range
    1.76 - 7.07
    LowHigh
  • (05/31/19 - 02/14/20)
    33.80%
  • 99.3%
  • Market Cap
    816.2M
  • Shares Outstanding
    174.4M
  • -0.58
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.3
  • 78.05
  • (% of float 05/15/20)
    7.44

Latest News

May 29, 2020
8:01 am ET
BusinessWire
May 21, 2020
9:33 am ET
PR Newswire
May 20, 2020
4:30 pm ET
BusinessWire
May 15, 2020
12:01 am ET
BusinessWire
May 13, 2020
5:01 pm ET
BusinessWire
May 06, 2020
4:30 pm ET
BusinessWire
May 04, 2020
4:05 pm ET
BusinessWire
May 01, 2020
6:30 am ET
BusinessWire
April 16, 2020
4:01 pm ET
BusinessWire
March 16, 2020
4:05 pm ET
Globe Newswire
December 19, 2019
12:51 pm ET
MarketWatch
December 17, 2019
4:00 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.